-
TherapeuticsMD Results 'Worse Than Expected'
Monday, May 8, 2017 - 8:45am | 453Read More...Shares of TherapeuticsMD Inc (NYSE: TXMD), a healthcare company that focuses on creating and commercializing products for women, fell more than 11 percent Monday morning after the company announced it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration. The...
-
TherapeuticsMD Plans On Raising $125 Million To Fund Commercialization Activities, Research & Clinical Trials
Wednesday, January 6, 2016 - 9:19am | 130Read More...Shares of TherapeuticsMD Inc (NYSE: TXMD) plunged more than 7 percent after Tuesday's market close following the company's announcement of a $125 million offering of common stock. TherapeuticsMD is a women's healthcare product company. The company plans on using the majority of the proceeds from...
